ADVERTISEMENT
Posted: Oct 7, 2023

First OTC oral contraceptive gains FDA approval, puts pharmacists in significant position

Woman's Health

Pharmacists can add norgestrel (Opill–Perrigo), a progestin-only birth control pill, to the list of reproductive health care options offered to patients.

Loren Bonner

Read more
Posted: Sep 7, 2023

Updates from FDA

New & Approved

Updates from FDA

Read more
Posted: Sep 7, 2023

Regaining those pearly whites

OTCs Today

Patient demand for tooth whitening has been on the increase for several years, bolstered by the availability of a wide variety of nonprescription whitening toothpastes and strips.

Mary Warner

Read more
Posted: Sep 7, 2023

Kiwifruit: It’s easy being green

On The Shelf

A recent study offers significant evidence of the beneficial effect of green kiwifruit for GI function and comfort.

Mickie Cathers

Read more
Posted: Sep 7, 2023

Testosterone-replacement therapy unlikely to increase risk of cardiac events

Heart Risk

Results of a recent trial published in the July 13, 2023, issue of NEJM found men 45 to 80 years old who took testosterone-replacement therapy were unlikely to experience an increased risk of major adverse cardiac events when compared to placebo.

Clarissa Chan, PharmD

Read more
First3132333436383940Last

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT